世界の血栓予防薬市場:販売動向2019

QYResearchが発行した調査報告書(DATA907A1556)
◆英語タイトル:Global Blood Clot Preventive Drugs Sales Market Report 2019
◆商品コード:DATA907A1556
◆発行会社(リサーチ会社):QYResearch
◆発行日:2019年8月(※2024年版があります。お問い合わせください。)
◆ページ数:102
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル
◆産業分野:医薬品・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD4,000 ⇒換算¥592,000見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD8,000 ⇒換算¥1,184,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はQYResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。

本調査レポートでは、血栓予防薬の世界市場について調査・分析し、血栓予防薬のメーカー別販売量、市場シェア分析、種類別販売分析(抗凝固薬、線溶薬、抗血小板薬)、用途別販売分析(Hospital Pharmacies、Retail Pharmacies、Online Pharmacies、Mail Order Pharmacies)、地域別販売分析(アメリカ、ヨーロッパ、中国、日本、東南アジア、インド)、価格動向、企業動向、市場規模予測などを含め、以下の構成でお届けいたします。

・血栓予防薬市場概要
・血栓予防薬のメーカー別販売量・メーカー別シェア
・血栓予防薬の種類別販売量(抗凝固薬、線溶薬、抗血小板薬)
・血栓予防薬の用途別販売量(Hospital Pharmacies、Retail Pharmacies、Online Pharmacies、Mail Order Pharmacies)
・血栓予防薬の地域別販売量・市場シェア
・血栓予防薬のアメリカ市場規模(2014年-2019年)
・血栓予防薬のヨーロッパ市場規模(2014年-2019年)
・血栓予防薬の中国市場規模(2014年-2019年)
・血栓予防薬の日本市場規模(2014年-2019年)
・血栓予防薬の東南アジア市場規模(2014年-2019年)
・血栓予防薬のインド市場規模(2014年-2019年)
・血栓予防薬メーカー分析(企業概要、製品概要、販売量、売上、価格等)
・血栓予防薬のコスト分析
・血栓予防薬販売チャネル、流通業者、顧客
・血栓予防薬の世界市場動向・機会・成長要因・課題
・血栓予防薬の種類別世界市場予測(抗凝固薬、線溶薬、抗血小板薬)
・血栓予防薬の用途別世界市場予測(Hospital Pharmacies、Retail Pharmacies、Online Pharmacies、Mail Order Pharmacies)
・血栓予防薬のアメリカ市場予測(2019年-2025年)
・血栓予防薬のヨーロッパ市場予測(2019年-2025年)
・血栓予防薬の中国市場予測(2019年-2025年)
・血栓予防薬の日本市場予測(2019年-2025年)
・血栓予防薬の東南アジア市場予測(2019年-2025年)
・血栓予防薬のインド市場予測(2019年-2025年)
...
【レポートの概要】

Thrombosis is the process of blood clots that form in the artery or veins. In this thrombosis condition, a clot blocks the flow of blood in the affected area and can create serious complications such as myocardial infraction, Strokes atherosclerotic plaque, among others. Deep vein thrombosis is condition clots that occur in leg or pelvis and if the clots broke off and reached to lungs known as pulmonary embolism.The increase in incidence of venous thromboembolism conditions, the rise in obese population, myocardial infractions, stroke, pulmonary embolism and genetically related disorders are the factors driving the growth of this market over the forecast period.  However, due to lack of awareness about venous thromboembolism conditions, side-effects caused due to current drugs are hindering the growth of blood clot prevention over the forecast period.

The global Blood Clot Preventive Drugs market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report studies the global Blood Clot Preventive Drugs market status and forecast, categorizes the global Blood Clot Preventive Drugs market size (value & volume) by key players, type, application, and region. This report focuses on the top players in North America, Europe, China, Japan, Southeast Asia India and Other regions (Middle East & Africa, Central & South America).

Major manufacturers covered in this report
Daiichi Sankyo Company
Janssen Pharmaceutical
Pfizer
Bayer
Boehringer Ingelheim
Bristol- Meyers Squibb
Portola Pharmaceuticals

In view of regional level, this report covers
United States
Europe
China
Japan
Southeast Asia
India

Segment by Type
Anticoagulants
Fibrinolytics
Anti-Platelet Drugs

Segment by Application
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Mail Order Pharmacies

【レポートの目次】

Table of Contents

Global Blood Clot Preventive Drugs Sales Market Report 2019
1 Blood Clot Preventive Drugs Market Overview
1.1 Blood Clot Preventive DrugsProduct Overview
1.2 Blood Clot Preventive Drugs Segment by Type
1.2.1 Global Blood Clot Preventive Drugs Sales Comparison by Types (2014-2025)
1.2.2 Anticoagulants
1.2.3 Fibrinolytics
1.2.4 Anti-Platelet Drugs
1.3 Blood Clot Preventive Drugs Segment by Application
1.3.1 Global Blood Clot Preventive Drugs Sales Comparison by Application (2014-2025)
1.3.1 Hospital Pharmacies
1.3.2 Retail Pharmacies
1.3.3 Online Pharmacies
1.3.4 Mail Order Pharmacies
1.4 Blood Clot Preventive Drugs Market by Region
1.4.1 Global Blood Clot Preventive Drugs Revenue Comparison by Region (2014-2025)
1.4.2 United States Blood Clot Preventive Drugs Status and Prospect (2014-2025)
1.4.3 Europe Blood Clot Preventive Drugs Status and Prospect (2014-2025)
1.4.4 China Blood Clot Preventive Drugs Status and Prospect (2014-2025)
1.4.5 Japan Blood Clot Preventive Drugs Status and Prospect (2014-2025)
1.4.6 Southeast Asia Blood Clot Preventive Drugs Status and Prospect (2014-2025)
1.4.7 India Blood Clot Preventive Drugs Status and Prospect (2014-2025)
1.5 Global Blood Clot Preventive Drugs Sales and Revenue (2014-2025)
1.5.1 Global Blood Clot Preventive Drugs Sales and Growth Rate (2014-2025)
1.5.2 Global Blood Clot Preventive Drugs Revenue and Growth Rate (2014-2025)

2 Blood Clot Preventive Drugs by Company, Region, Type and Application
2.1 Global Blood Clot Preventive Drugs Market Competition by Companies
2.1.1 Global Blood Clot Preventive Drugs Sales Market Share of Key Companies (2014-2019)
2.1.2 Global Blood Clot Preventive Drugs Revenue Market Share by Company (2014-2019)
2.2 Global Blood Clot Preventive Drugs Sales and Revenue by Region
2.2.1 Global Blood Clot Preventive Drugs Sales Market Share by Region (2014-2019)
2.2.2 Global Blood Clot Preventive Drugs Revenue Market Share by Region (2014-2019)
2.3 Global Blood Clot Preventive Drugs Sales and Revenue by Type
2.3.1 Global Blood Clot Preventive Drugs Sales Market Share by Type (2014-2019)
2.3.2 Global Blood Clot Preventive Drugs Revenue Market Share by Type (2014-2019)
2.4 Global Blood Clot Preventive Drugs Sales by Application

3 United States Blood Clot Preventive Drugs Sales, Revenue and Price
3.1 United States Blood Clot Preventive Drugs Sales and Revenue (2014-2019)
3.1.1 United States Blood Clot Preventive Drugs Sales Growth Rate (2014-2019)
3.1.2 United States Blood Clot Preventive Drugs Revenue Growth Rate (2014-2019)
3.1.3 United States Blood Clot Preventive Drugs Price Trend (2014-2019)
3.2 United States Blood Clot Preventive Drugs Sales Market Share by Company
3.3 United States Blood Clot Preventive Drugs Sales Market Share by Type
3.4 United States Blood Clot Preventive Drugs Sales Market Share by Application

4 Europe Blood Clot Preventive Drugs Sales, Revenue and Price
4.1 Europe Blood Clot Preventive Drugs Sales and Value (2014-2019)
4.1.1 Europe Blood Clot Preventive Drugs Sales Growth Rate (2014-2019)
4.1.2 Europe Blood Clot Preventive Drugs Revenue Growth Rate (2014-2019)
4.1.3 Europe Blood Clot Preventive Drugs Price Trend (2014-2019)
4.2 Europe Blood Clot Preventive Drugs Sales Market Share by Company
4.3 Europe Blood Clot Preventive Drugs Sales Market Share by Type
4.4 Europe Blood Clot Preventive Drugs Sales Market Share by Application

5 China Blood Clot Preventive Drugs Sales, Revenue and Price
5.1 China Blood Clot Preventive Drugs Sales and Revenue (2014-2019)
5.1.1 China Blood Clot Preventive Drugs Sales Growth Rate (2014-2019)
5.1.2 China Blood Clot Preventive Drugs Revenue Growth Rate (2014-2019)
5.1.3 China Blood Clot Preventive Drugs Price Trend (2014-2019)
5.2 China Blood Clot Preventive Drugs Sales Market Share by Company
5.3 China Blood Clot Preventive Drugs Sales Market Share by Type
5.4 China Blood Clot Preventive Drugs Sales Market Share by Application

6 Japan Blood Clot Preventive Drugs Sales, Revenue and Price
6.1 Japan Blood Clot Preventive Drugs Sales and Value (2014-2019)
6.1.1 Japan Blood Clot Preventive Drugs Sales Growth Rate (2014-2019)
6.1.2 Japan Blood Clot Preventive Drugs Revenue Growth Rate (2014-2019)
6.1.3 Japan Blood Clot Preventive Drugs Price Trend (2014-2019)
6.2 Japan Blood Clot Preventive Drugs Sales Market Share by Company
6.3 Japan Blood Clot Preventive Drugs Sales Market Share by Type
6.4 Japan Blood Clot Preventive Drugs Sales Market Share by Application

7 Southeast Asia Blood Clot Preventive Drugs Sales, Revenue and Price
7.1 Southeast Asia Blood Clot Preventive Drugs Sales and Value (2014-2019)
7.1.1 Southeast Asia Blood Clot Preventive Drugs Sales Growth Rate (2014-2019)
7.1.2 Southeast Asia Blood Clot Preventive Drugs Revenue Growth Rate (2014-2019)
7.1.3 Southeast Asia Blood Clot Preventive Drugs Price Trend (2014-2019)
7.2 Southeast Asia Blood Clot Preventive Drugs Sales Market Share by Company
7.3 Southeast Asia Blood Clot Preventive Drugs Sales Market Share by Type
7.4 Southeast Asia Blood Clot Preventive Drugs Sales Market Share by Application

8 India Blood Clot Preventive Drugs Sales, Revenue and Price
8.1 India Blood Clot Preventive Drugs Sales and Value (2014-2019)
8.1.1 India Blood Clot Preventive Drugs Sales Growth Rate (2014-2019)
8.1.2 India Blood Clot Preventive Drugs Revenue Growth Rate (2014-2019)
8.1.3 India Blood Clot Preventive Drugs Price Trend (2014-2019)
8.2 India Blood Clot Preventive Drugs Sales Market Share by Company
8.3 India Blood Clot Preventive Drugs Sales Market Share by Type
8.4 India Blood Clot Preventive Drugs Sales Market Share by Application

9 Company Profiles and Key Figures in Blood Clot Preventive Drugs Business
9.1 Daiichi Sankyo Company
9.1.1 Daiichi Sankyo Company Blood Clot Preventive Drugs Production Sites and Area Served
9.1.2 Blood Clot Preventive Drugs Specification and Application
9.1.3 Daiichi Sankyo Company Blood Clot Preventive Drugs Sales, Revenue, Price and Gross Margin (2014-2019)
9.1.4 Main Business and Markets Served
9.2 Janssen Pharmaceutical
9.2.1 Janssen Pharmaceutical Blood Clot Preventive Drugs Production Sites and Area Served
9.2.2 Blood Clot Preventive Drugs Specification and Application
9.2.3 Janssen Pharmaceutical Blood Clot Preventive Drugs Sales, Revenue, Price and Gross Margin (2014-2019)
9.2.4 Main Business and Markets Served
9.3 Pfizer
9.3.1 Pfizer Blood Clot Preventive Drugs Production Sites and Area Served
9.3.2 Blood Clot Preventive Drugs Specification and Application
9.3.3 Pfizer Blood Clot Preventive Drugs Sales, Revenue, Price and Gross Margin (2014-2019)
9.3.4 Main Business and Markets Served
9.4 Bayer
9.4.1 Bayer Blood Clot Preventive Drugs Production Sites and Area Served
9.4.2 Blood Clot Preventive Drugs Specification and Application
9.4.3 Bayer Blood Clot Preventive Drugs Sales, Revenue, Price and Gross Margin (2014-2019)
9.4.4 Main Business and Markets Served
9.5 Boehringer Ingelheim
9.5.1 Boehringer Ingelheim Blood Clot Preventive Drugs Production Sites and Area Served
9.5.2 Blood Clot Preventive Drugs Specification and Application
9.5.3 Boehringer Ingelheim Blood Clot Preventive Drugs Sales, Revenue, Price and Gross Margin (2014-2019)
9.5.4 Main Business and Markets Served
9.6 Bristol- Meyers Squibb
9.6.1 Bristol- Meyers Squibb Blood Clot Preventive Drugs Production Sites and Area Served
9.6.2 Blood Clot Preventive Drugs Specification and Application
9.6.3 Bristol- Meyers Squibb Blood Clot Preventive Drugs Sales, Revenue, Price and Gross Margin (2014-2019)
9.6.4 Main Business and Markets Served
9.7 Portola Pharmaceuticals
9.7.1 Portola Pharmaceuticals Production Sites and Area Served
9.7.2 Blood Clot Preventive Drugs Specification and Application
9.7.3 Portola Pharmaceuticals Blood Clot Preventive Drugs Sales, Revenue, Price and Gross Margin (2014-2019)
9.7.4 Main Business and Markets Served

10 Blood Clot Preventive Drugs Maufacturing Cost Analysis
10.1 Blood Clot Preventive Drugs Key Raw Materials Analysis
10.1.1 Key Raw Materials
10.1.2 Key Raw Materials Price Trend
10.1.3 Key Suppliers of Raw Materials
10.2 Proportion of Manufacturing Cost Structure
10.3 Manufacturing Process Analysis of Blood Clot Preventive Drugs
10.4 Blood Clot Preventive Drugs Industrial Chain Analysis

11 Marketing Channel, Distributors and Customers
11.1 Marketing Channel
11.1.1 Direct Marketing
11.1.2 Indirect Marketing
11.2 Blood Clot Preventive Drugs Distributors List
11.3 Blood Clot Preventive Drugs Customers

12 Market Dynamics
12.1 Market Trends
12.2 Opportunities
12.3 Market Drivers
12.4 Challenges
12.5 Influence Factors

13 Blood Clot Preventive Drugs Market Forecast
13.1 Global Blood Clot Preventive Drugs Sales, Revenue and Price Forecast
13.1.1 Global Blood Clot Preventive Drugs Sales Growth Forecast (2019-2025)
13.1.2 Global Blood Clot Preventive Drugs Revenue Growth Forecast (2019-2025)
13.1.3 Global Blood Clot Preventive Drugs Price Trend Forecast (2019-2025)
13.2 Global Blood Clot Preventive Drugs Forecast by Region
13.2.1 Global Blood Clot Preventive Drugs Sales Growth Forecast by Region (2019-2025)
13.2.2 Global Blood Clot Preventive Drugs Revenue Growth Forecast by Region (2019-2025)
13.2.3 United States Blood Clot Preventive Drugs Sales, Revenue Growth Forecast (2019-2025)
13.2.4 Europe Blood Clot Preventive Drugs Sales, Revenue Growth Forecast (2019-2025)
13.2.5 China Blood Clot Preventive Drugs Sales, Revenue Growth Forecast (2019-2025)
13.2.6 Japan Blood Clot Preventive Drugs Sales, Revenue Growth Forecast (2019-2025)
13.2.7 Southeast Asia Blood Clot Preventive Drugs Sales, Revenue Growth Forecast (2019-2025)
13.2.8 India Blood Clot Preventive Drugs Sales, Revenue Growth Forecast (2019-2025)
13.3 Global Blood Clot Preventive Drugs Forecast by Type
13.3.1 Global Blood Clot Preventive Drugs Sales Forecast by Type (2019-2025)
13.3.2 Global Blood Clot Preventive Drugs Revenue Forecast by Type (2019-2025)
13.3.3 Global Blood Clot Preventive Drugs Price Forecast by Type (2019-2025)
13.4 Global Blood Clot Preventive Drugs Forecast by Application

14 Research Findings and Conclusion

15 Methodology and Data Source
15.1 Methodology/Research Approach
15.1.1 Research Programs/Design
15.1.2 Market Size Estimation
15.1.3 Market Breakdown and Data Triangulation
15.2 Data Source
15.2.1 Secondary Sources
15.2.2 Primary Sources
15.3 Author List
15.4 Disclaimer

...

【免責事項】
https://www.globalresearch.jp/disclaimer

★リサーチレポート[ 世界の血栓予防薬市場:販売動向2019(Global Blood Clot Preventive Drugs Sales Market Report 2019)]についてメールでお問い合わせはこちらでお願いします。